Prospective Assessment of Motor Neurotoxicity and Sarcopenia in CD30+ Lymphoma Patients Treated with Brentuximab Vedotin. Single Center Multidisciplinary Unit Experience

Prospective Assessment of Motor Neurotoxicity and Sarcopenia in CD30+ Lymphoma Patients Treated with Brentuximab Vedotin. Single Center Multidisciplinary Unit Experience

Saved in:
Bibliographic Details
Published in:Blood Vol. 140; no. Supplement 1; pp. 9420 - 9421
Main Authors: Eva, Domingo Domenech, Bellver, Marta, Ferrer, German, Gonzalez Barca, Eva, Carro, Itziar, Oliveira, Ana C, Lopez, Patricia, Sanz-Linares, Gabriela, Aguilera, Carmen, Alemany, Montserrat, Peiro, Inmaculada, Sureda, Anna, Velasco, Roser
Format: Journal Article
Language:English
Published: Elsevier Inc 15-11-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-165345